Platinum Investment Management’s Assembly Biosciences ASMB Stock Holding History

Platinum Investment Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-74,228	Closed	-$749K	–	144
2023 Q1	$749K	Sell	74,228 -17,003	-19%	-$287K	0.03%	106
2022 Q4	$1.42M	Sell	91,231 -29,630	-25%	-$507K	0.05%	93
2022 Q3	$2.38M	Sell	120,861 -11,745	-9%	-$284K	0.1%	68
2022 Q2	$3.34M	Sell	132,606 -26,519	-17%	-$610K	0.13%	62
2022 Q1	$3.93M	Hold	159,125	–	–	0.12%	62
2021 Q4	$4.45M	Buy	159,125 +21,374	+16%	+$701K	0.12%	67
2021 Q3	$5.75M	Hold	137,751	–	–	0.16%	59
2021 Q2	$6.41M	Buy	137,751 +18,491	+16%	+$916K	0.15%	59
2021 Q1	$6.58M	Buy	119,260 +50,769	+74%	+$3.36M	0.15%	48
2020 Q4	$4.97M	Buy	68,491 +49,750	+265%	+$5.84M	0.11%	58
2020 Q3	$3.7M	Buy	18,741 +5,828	+45%	+$1.47M	0.09%	61
2020 Q2	$3.61M	Hold	12,913	–	–	0.08%	60
2020 Q1	$2.3M	Buy	+12,913	New	+$2.77M	0.06%	69

Other funds holding ASMB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Platinum Investment Management's ASMB Position: Q2 2023 in Review

Platinum Investment Management sold out of Assembly Biosciences (ASMB) in Q2 2023, closing a stake of 74,228 shares — an estimated $749K sold.

Platinum Investment Management first reported a position in ASMB in Q1 2020 and held it in 13 quarters. The position peaked at $6.58M in Q1 2021. 32 funds tracked by Wall St. Rank hold ASMB as of Q2 2023.

Platinum Investment Management reported no remaining Assembly Biosciences position as of Q2 2023 after selling out during the quarter.
Platinum Investment Management sold 74,228 Assembly Biosciences shares in Q2 2023, an estimated $749K.
Platinum Investment Management first reported a position in Assembly Biosciences in Q1 2020 and held it in 13 quarters.
Platinum Investment Management's Assembly Biosciences position peaked at $6.58M in Q1 2021.
32 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2023.

Based on Platinum Investment Management's 13F filing for Q2 2023, filed 11 Aug 2023.